Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 214 publications
Focused ultrasound to track circulating extracellular vesicles in glioblastoma.
Journal: Neuro-oncology
Published: August 03, 2026
A proteogenomic RNA processing mechanism drives sex differences in meningioma.
Journal: Research square
Published: June 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.
Journal: Research square
Published: June 12, 2026
A proteogenomic RNA processing mechanism drives sex differences in meningioma.
Journal: Research square
Published: June 12, 2026
Androgens drive tumor cell-autonomous and cell-nonautonomous sex differences in brain tumors.
Journal: Neuro-oncology
Published: May 18, 2026
Prospective consecutive genomic profiling defines the distribution of meningioma molecular alterations across demographic groups.
Journal: Neuro-oncology
Published: May 05, 2026
Risk stratification for meningiomas with discordant molecular classification.
Journal: Acta neuropathologica
Published: April 20, 2026
Prospective Genomic Profiling of Consecutive Meningiomas.
Journal: JAMA oncology
Published: April 09, 2026
Integrating molecular classification into postoperative intracranial meningioma management.
Journal: Neurosurgical focus
Published: March 15, 2026
MRI Features for Differentiation of Meningioma DNA Methylation Groups.
Journal: AJNR. American journal of neuroradiology
Published: March 05, 2026
Epidemiological and clinical data link depot medroxyprogesterone acetate to meningioma.
Journal: Neuro-oncology
Published: February 17, 2026
Stratification by Ki-67 Labeling Index Increases Specificity of p16INK4a Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 17, 2026
Last Updated: 09/26/2026